The Development of Stem Cell-Based Treatment for Acute Ischemic Cerebral Injury

Curr Stem Cell Res Ther. 2020;15(6):509-521. doi: 10.2174/1574888X15666200331135227.

Abstract

Acute ischemic brain injury is a serious disease that severely endangers the life safety of patients. Such disease is hard to predict and highly lethal with very limited effective treatments currently. Although currently, there exist treatments like drug therapy, hyperbaric oxygen therapy, rehabilitation therapy and other treatments in clinical practice, these are not significantly effective for patients when the situation is severe. Thus scientists must explore more effective treatments. Stem cells are undifferentiated cells with a strong potential of self-renewal and differentiate into various types of tissues and organs. Their emergence has brought new hopes for overcoming difficult diseases, further improving medical technology and promoting the development of modern medicine. Some combining therapies and genetically modified stem cell therapy have also been proven to produce obvious neuroprotective function for acute ischemic brain injury. This review is an introduction to the current research findings and discusses the definition, origin and classification of stem cells, as well as the future prospects of the stem cell-based treatment for acute ischemic cerebral injury.

Keywords: Acute ischemia; cerebral injury; gene therapy; neuroprotective agent; stem cells; treatment.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain Injuries / complications
  • Brain Injuries / therapy*
  • Brain Ischemia / complications
  • Brain Ischemia / therapy*
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Humans
  • Stem Cell Research
  • Stem Cell Transplantation*